Despite patient beliefs, no impact seen on severity, duration of cough.
Respiratory Disorders
— DRUG MONOGRAPHS BY SUBSECTION —
News and Features
Unpacking and figuring out how to use an anti-choking device can waste valuable time, the agency said
The double-blind, phase 3 study included 2 groups of patients, those who were not on positive airway pressure therapy and those who were.
Risk for experiencing acute cardiac event higher for adults with underlying cardiovascular disease
The Bluetooth-enabled Hailie sensor attaches to the inhaler and is then paired with the Hailie app.
Asthma treatment gains approval for severe cases in pediatrics; Dovato gains expanded indication; Decision taken to remove ALS drug from market; Complete Response Letter issued for apomorphine device; At-home Mpox test kit made available.
Previously, the treatment had only been approved for patients 12 years and older.
After 12 days on the transplant wait list, Gibbon received his new lungs and liver from the same donor during a 10-hour surgical procedure.
Participants were asked to rank products in 132 OTC categories.
Winrevair is a first-in-class recombinant activin receptor type IIA-Fc fusion protein designed to bind to activin A and other TGF-β superfamily ligands.
Nasal spray approved for chronic rhinosinusitis; Endothelin receptor antagonist gains approval to lower blood pressure in hypertension; One-time stem cell treatment approved for metachromatic leukodystrophy; NASH treatment gains accelerated approval; New automated insulin delivery system for type 1 diabetes.
Researchers estimated the attributable costs of RSV-LRTI in US adults, both during the acute phase of illness and up to 1 year after.
Researchers assessed RSV-associated ALRI global disease burden and risk factors among infants and young children born preterm.
According to the Company, the new program will begin no later than January 1, 2025.
Researchers examined the use of palivizumab among immunocompromised children for the prevention of severe respiratory syncytial virus disease.
Investigators reviewed recent recommendations for RSV prevention during pregnancy and addressed potential challenges for RSV vaccination.
Starting June 1, 2024, eligible patients will pay no more than $35 per month for the following AstraZeneca inhalers: Airsupra, Bevespi Aerosphere, Breztri Aerosphere, and Symbicort.
Researchers examined the efficacy and safety of the respiratory syncytial virus (RSV) prefusion F protein-based vaccine among older adults over 2 RSV seasons.
However, RSV prefusion F protein-based maternal vaccine appears to raise risk for preterm birth
- Loading...
